KDM1A and breast cancer: Previous studies have shown that DHT-activated AR interacts with demethylase LSD1 to repress E-cadherin transcription and upregulate vimentin transcription in the ER and AR positive MCF7 breast cancer cells, leading to EMT that increases cell migration and invasion [27].